ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 294 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $6,554,000 | -31.4% | 162,159 | -2.3% | 0.09% | -32.1% |
| Q2 2015 | $9,549,000 | +31.8% | 165,926 | +45.8% | 0.13% | +17.5% |
| Q1 2015 | $7,246,000 | +48.3% | 113,807 | +43.8% | 0.11% | +54.1% |
| Q4 2014 | $4,885,000 | +42.9% | 79,125 | -10.1% | 0.07% | +39.6% |
| Q3 2014 | $3,418,000 | +66.4% | 88,030 | +47.6% | 0.05% | +65.6% |
| Q2 2014 | $2,054,000 | +2.6% | 59,626 | +28.7% | 0.03% | -5.9% |
| Q1 2014 | $2,002,000 | +1234.7% | 46,323 | +1059.8% | 0.03% | +1033.3% |
| Q3 2013 | $150,000 | -86.7% | 3,994 | -90.5% | 0.00% | -89.3% |
| Q2 2013 | $1,125,000 | – | 41,854 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 7,202,585 | $270,385,000 | 14.71% |
| DOWLING & YAHNKE LLC | 675,798 | $25,369,000 | 3.98% |
| GARRISON BRADFORD & ASSOCIATES INC | 100,700 | $3,780,000 | 3.87% |
| WILLIAM HARRIS INVESTORS INC | 312,834 | $11,743,000 | 3.67% |
| Meditor Group Ltd | 490,000 | $18,395,000 | 2.59% |
| AVALON CAPITAL MANAGEMENT | 50,943 | $1,912,000 | 1.89% |
| Orinda Asset Management LLC | 14,665 | $551,000 | 1.73% |
| PINNACLE ASSOCIATES LTD | 2,064,760 | $77,511,000 | 1.60% |
| PERKINS CAPITAL MANAGEMENT INC | 52,850 | $1,984,000 | 1.43% |
| NCM Capital Advisers, Inc. | 24,950 | $937,000 | 1.04% |